PLYMOUTH MEETING, Pa., Aug. 4, 2023 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that it has made equity grants to two newly hired employees under its 2022 Inducement…Read More
INOVIO Reports Inducement Grants Under Inducement Plan
